Odonate Therapeutics, Inc.
ODTC · OTC
12/31/2022 | 9/30/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11 | $43 | $69 | $95 |
| Short-Term Investments | $37 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $6 | $4 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $48 | $43 | $75 | $100 |
| Property Plant & Equip (Net) | $1 | $1 | $3 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $22 | $22 | $1 | $1 |
| Tax Assets | $33 | $34 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $55 | $57 | $4 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $104 | $99 | $79 | $106 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $12 |
| Short-Term Debt | $0 | $0 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $15 | $18 |
| Total Curr. Liab. | $1 | $1 | $16 | $30 |
| LT Debt | $2 | $2 | $4 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $2 | $4 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $4 | $5 |
| Total Liabilities | $3 | $3 | $20 | $34 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$392 | -$397 | -$435 | -$436 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $492 | $492 | $494 | $507 |
| Total Equity | $101 | $96 | $59 | $71 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $104 | $99 | $79 | $106 |
| Net Debt | -$8 | -$40 | -$64 | -$90 |